NCT01476904 - Safety Study in Adolescent and Adult Patients With Asthma | Biotech Hunter

Enrollment

208

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

July 31, 2012

Conditions

Asthma

Interventions

DRUG

Placebo

0 mcg/inhalation, 2 inhalations QID

DRUG

Primatene Mist

220 mcg/inhalation, 2 inhalations QID

DRUG

Epinephrine inhalation

125 mcg/inhalation, 2 inhalations QID

Trial Locations (27)

23229

Amphastar Site 0033, Richmond

27607

Amphastar Site 0018, Raleigh

29406

Amphastar Site 0029, North Charleston

45242

Amphastar Site 0021, Cincinnati

52240

Amphastar Site 0011, Iowa City

55402

Amphastar Site 0014, Minneapolis

55441

Amphastar Site 0015, Plymouth

59718

Amphastar Site 0017, Bozeman

63141

Amphastar Site 0016, St Louis

68123

Amphastar Site 0019, Bellevue

78130

Amphastar Site 0030, New Braunfels

79903

Amphastar Site 0031, El Paso

80033

Amphastar Site 0009, Wheat Ridge

80230

Amphastar Site 0008, Denver

90048

Amphastar Site 0005, Los Angeles

92626

Amphastar Site 0006, Costa Mesa

92868

Amphastar Site 0004, Orange

95117

Amphastar Site 0001, San Jose

95207

Amphastar Site 0003, Stockton

97035

Amphastar Site 0023, Lake Oswego

97202

Amphastar Site 0026, Portland

97401

Amphastar Site 0022, Eugene

97504

Amphastar Site 0025, Medford

97520

Amphastar Site 0024, Ashland

98105

Amphastar Site 0034, Seattle

02747

Amphastar Site 0013, North Dartmouth

08558

Amphastar Site 0020, Skillman